|
|
多模态超声技术联合粪便钙卫蛋白评估炎症性肠病的临床研究
|
Abstract:
目的：研究多模态超声技术联合粪便钙卫蛋白水平评估炎症性肠病的临床意义。方法：回顾性分析2022年1月~2023年10月在扬州大学附属医院接收诊疗的95例炎症性肠病患者的临床资料。根据简化克罗恩病活动指数将患者分为缓解期和活动期，并分别比较缓解期和活动期患者常规二维超声、彩色多普勒和超声造影的检查数据以及住院患者的粪便钙卫蛋白水平。结果：缓解期和活动期患者肠壁厚度、血流分级、超声造影定量参数(PI、WoAUC、FT和mTT)之间存在统计学差异(p < 0.05)。结论：多模态超声联合粪便钙卫蛋白水平评估炎症性肠病炎症反应的严重程度具有一定临床指导意义。
Purpose: This study aimed to assess the clinical significance of multimodal ultrasound combined with fecal calprotectin levels in the evaluation of inflammatory bowel disease (IBD). Methods: We conducted a retrospective analysis of clinical data from 95 patients with IBD treated at Yangzhou University Affiliated Hospital between January 2022 and October 2023. Patients were categorized into remission and active phases based on the Simplified Crohn’s Disease Activity Index. We compared routine two-dimensional ultrasound, color Doppler, and contrast-enhanced ultrasound findings between patients in remission and active phases, as well as fecal calprotectin levels in hospitalized patients. Results: Significant statistical differences (p < 0.05) were observed in intestinal wall thickness, blood flow grading, and quantitative parameters from contrast-enhanced ultrasound (Peak Kinetic Index, Washout Area under the Curve, Final Time, and mean Transit Time) between patients in remission and active phases. Conclusion: Multimodal ultrasound combined with fecal calprotectin levels provides valuable clinical insights into assessing the severity of inflammatory bowel disease inflammation.
| [1] | Zhang, F., Miao, L.Y., Ge, H.Y., Tan, S, Li, Z.Q. and Zhao, B. (2018) Usefulness of Contrast-Enhanced Ultrasound in Differentiating Inflammatory Bowel Disease from Colon Cancer. Ultrasound in Medicine and Biology, 44, 124-133. https://doi.org/10.1016/j.ultrasmedbio.2017.09.016 |
| [2] | Yang, H., Li, Y.M., Wu, W., Sun, Q.W., Zhang, Y.Z., Zhao, W., Lv, H.B., Xia, Q., Hu, P.J., Li, H.H. and Qian, J.M. (2014) The Incidence of Inflammatory Bowel Disease in Northern China: A Prospective Population-Based Study. PLOS ONE, 9, E101296. https://doi.org/10.1371/journal.pone.0101296 |
| [3] | Bremner, A.R., Griffiths, M., Argent, J.D., Fairhurst, J.J. and Beattie, R.M. (2006) Sonographic Evaluation of Inflammatory Bowel Disease: A Prospective, Blinded, Comparative Study. Pediatric Radiology, 36, 947-953. https://doi.org/10.1007/s00247-006-0245-8 |
| [4] | Gao, J., Ng, A., Dang, M.-N.Y. and Min, R. (2010) Flow Turbulence or Twinkling Artifact? A Primary Observation on the Intrarenal Color Doppler Sonography. Clinical Imaging, 34, 355-360. https://doi.org/10.1016/j.clinimag.2009.08.029 |
| [5] | Tokodai, K., Miyagi, S., Nakanishi, C., Hara, Y., Nakanishi, W., Miyazawa, K., Shimizu, K., Goto, M., Kamei, T. and Unno, M. (2018) The Utility of Superb Microvascular Imaging for Monitoring Low-Velocity Venous Flow Following Pancreas Transplantation: Report of a Case. Journal of Medical Ultrasonics, 45, 171-174. https://doi.org/10.1007/s10396-017-0795-4 |
| [6] | Conti, C.B., Giunta, M., Gridavilla, D., Conte, D. and Fraquelli, M. (2017) Role of Bowel Ultrasound in the Diagnosis and Follow-Up of Patients with Crohn’s Disease. Ultrasound in Medicine and Biology, 43, 725-734. https://doi.org/10.1016/j.ultrasmedbio.2016.12.014 |
| [7] | Kubale, R. and Arning, C. (2004) Significance of Doppler Ultrasound Procedures for Diagnosis of Carotid Stenoses. Radiologe, 44, 946-959. https://doi.org/10.1007/s00117-004-1118-5 |
| [8] | Gokli, A., Dillman, J.R., Humphries, P.D., Klju？ev？ek, D., Mentzel, H.J., Rubesova, E., Takahashi, M.S. and Anupindi, S.A. (2021) Contrast-Enhanced Ultrasound of the Pediatric Bowel. Pediatric Radiology, 51, 2214-2228. https://doi.org/10.1007/s00247-020-04868-x |
| [9] | Jang, H.W., Kim H.S., Park, S.J., Hong, S.P., Kim, T.I., Kim, W.H. and Cheon, J.H. (2016) Accuracy of Three Different Fecal Calprotectin Tests in the Diagnosis of Inflammatory Bowel Disease. Intestinal Research, 14, 305-313. https://doi.org/10.5217/ir.2016.14.4.305 |
| [10] | Sharbatdaran, M., Halakou, A., Kashifard, M., Bijani, A., Firozjaei, A., Hossaini, A. and Siadati, S. (2018) Fecal Calprotectin Level in Patients with IBD and Noninflammatory Disease of Colon: A Study in Babol, Northern, Iran. Caspian Journal of Internal Medicine, 9, 60-64. |
| [11] | Khaki-Khatibi, F., Qujeq, D., Kashifard, M., Moein, S. Maniati, M. and Vaghari-Tabari, M. (2020) Calprotectin in Inflammatory Bowel Disease. Clinica Chimica Acta, 510, 556-565. https://doi.org/10.1016/j.cca.2020.08.025 |
| [12] | Liu F., Lee, S.A., Riordan, S.M., Zhang, L. and Zhu, L.X. (2020) Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease. Frontiers in Medicine, 2020, Article 580803. https://doi.org/10.3389/fmed.2020.580803 |
| [13] | Xu J.H., Chen, X.J., Ma K.J., Nie, K., Luo, W.W., Wu, X., Pan, S.Y. and Wang, X.Y. (2021) Correlation Between Sleep, Life, Mood, and Diet and Severity of Inflammatory Bowel Disease in China: A Retrospective Study. Medical Science Monitor, 27, E930511-1–E930511-10. https://doi.org/10.12659/MSM.930511 |
| [14] | Zhao, X.J., Li, L.Z., Li X.T., Li J.J., Wang, D. and Zhang H.J. (2019) The Relationship Between Serum Bilirubin and Inflammatory Bowel Disease. Mediators of Inflammation, 2019, Article 5256460. https://doi.org/10.1155/2019/5256460 |
| [15] | Wang D., Zhao X.J., Cui X.F., Li, L.Z. and Zhang, H.J. (2021) Correlation of Serum Lipid Profile and Disease Activity in Patients with Inflammatory Bowel Disease. Chinese Journal of Internal Medicine, 60, 834-836. |
| [16] | Harris, N.R., Carter, P.R., Lee, S., Watts, M.N., Zhang, S.L. and Grisham, M.B. (2010) Association Between Blood Flow and Inflammatory State in a T-Cell Transfer Model of Inflammatory Bowel Disease in Mice. Inflammatory Bowel Diseases, 16, 776-782. https://doi.org/10.1002/ibd.21126 |
| [17] | Alkim, C., Alkim, H., Koksal, A.R., Boga, S. and Sen, I. (2015) Angiogenesis in Inflammatory Bowel Disease. International Journal of Inflammation, 2015, Article 970890. https://doi.org/10.1155/2015/970890 |
| [18] | Hejl, J., Theede, K., M？llgren, B., Madsen, K.V., Heidari, A., Steig, A. and Fenger, M. (2018) Point of Care Testing of Fecal Calprotectin as a Substitute for Routine Laboratory Analysis. Practical Laboratory Medicine, 10, 10-14. https://doi.org/10.1016/j.plabm.2017.11.002 |
| [19] | D’Haens, G., Ferrante, M., Vermeire, S., Baert, F., Noman, M., Moortgat, L., Geens, P., Iwens. D., Aerden, I., Van, A.G., Van, O.G. and Rutgeerts, P. (2012) Fecal Calprotectin Is a Surrogate Marker for Endoscopic Lesions in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 18, 2218-2224. https://doi.org/10.1002/ibd.22917 |
| [20] | Van Wassenaer, E.A., Diederen, K., Van Leeuwen, E.M.M., D’Haens, G.R., Benninga, M.A. Koot, B.G.P. and Kindermann, A. (2022) Can 2 Different Fecal Calprotectin Assays Be Used Interchangeably in IBD Treatment? Journal of Clinical Gastroenterology, 56, E27-E30. https://doi.org/10.1097/MCG.0000000000001460 |
| [21] | Bertani, L., Mumolo, M.G., Tapete, G., Albano, E., Baiano, S.G., Zanzi, F., Ceccarelli, L., Bellini M., Marchi, S. and Costa F. (2020) Fecal Calprotectin: Current and Future Perspectives for Inflammatory Bowel Disease Treatment. European Journal of Gastroenterology & Hepatology, 32, 1091-1098. https://doi.org/10.1097/MEG.0000000000001731 |
| [22] | Kato, J., Hiraoka, S., Nakarai, A., Takashima, S., Inokuchi, T. and Ichinose, M. (2016) Fecal Immunochemical Test as a Biomarker for Inflammatory Bowel Diseases: Can It Rival Fecal Calprotectin? Intestinal Research, 14, 5-14. https://doi.org/10.5217/ir.2016.14.1.5 |
